Alnylam has said it will not proceed with a clinical trial of its RNAi drug vutrisiran in the rare eye disorder Stargardt disease – at least for now – tying its decision to President Joe Biden ...

The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions. However, while scientific breakthroughs in regenerative medicines ...

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include ...

Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceuticals' etrasimod in ulcerative colitis (UC) when it acquired the company earlier this year, and the gamble ...

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically cleared for folate receptor-alpha (FRα) positive, platinum-resistant ...

As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional ...

With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact. The past eight years are set to be the eight warmest ...

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...

AbbVie has boosted its Alzheimer's disease pipeline with a $1.4 billion cash deal to buy Aliada Therapeutics and its anti-amyloid antibody ALIA-1758, which is in phase 1 testing. If consummated ...

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

There are many outputs produced during a clinical trial, and one of the most crucial is the Clinical Study Report (CSR). It details the results, methodology, and analysis of the trial, providing ...